bromfenac has been researched along with Miosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY | 1 |
Chen, H; Chen, W; Li, J; Lin, H; Xiang, W; Zhang, B | 1 |
Francis, P; Jones, J | 1 |
1 review(s) available for bromfenac and Miosis
Article | Year |
---|---|
Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Cells, Cultured; Conjunctivitis, Allergic; Eye Diseases; Humans; Macular Edema; Miosis; Ophthalmic Solutions; Pain, Postoperative; Toxicity Tests; Treatment Outcome; Uveitis, Anterior | 2009 |
2 trial(s) available for bromfenac and Miosis
Article | Year |
---|---|
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Female; Humans; Inflammation; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Miosis; Phacoemulsification; Postoperative Complications; Postoperative Period; Premedication; Treatment Outcome | 2015 |
Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E
Topics: Administration, Topical; Aged; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Double-Blind Method; Female; Humans; Intraoperative Complications; Lasers; Male; Middle Aged; Miosis; Prospective Studies; Receptors, Prostaglandin E, EP2 Subtype; Time Factors | 2017 |